Master Alliance Provisions Guide (MAPGuide)

European Commission – AstraZeneca, COVID-19 Vaccine Advance Purchase Agreement

  • Consortium structure & management

Section 3.1 Order Form

(a) Attached as Exhibit A to this Agreement is an Order Form which has been negotiated on behalf of the Member States by the Commission. In order to maintain the right to purchases Doses of Vaccine as contemplated by this Agreement, an EU Member State must execute and deliver an Order Form in the form of Exhibit A with the information relevant to such member state filled in.

(b) The Parties acknowledge and agree that the Order From is an essential and important part of this Agreement and AstraZeneca has entered into this Agreement in reliance on Member States executing such Order Forms as contemplated hereby Such Order Forms have to be entered into by each of the Participating Member States within 10 working days following the delivery by the Commission of the Binding Allocation according to Section 8.3 (a) If an EU Member State does not execute and deliver an Order Form within such deadline such Member State shall not be eligible to receive any portion of the Initial Europe Doses, the Optional Doses and the Additional Doses under this Agreement and shall not be entitled to any benefit of this Agreement.